400 related articles for article (PubMed ID: 8631347)
1. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
Petersen LC; Bjørn SE; Olsen OH; Nordfang O; Norris F; Norris K
Eur J Biochem; 1996 Jan; 235(1-2):310-6. PubMed ID: 8631347
[TBL] [Abstract][Full Text] [Related]
2. Enhanced plasmin inhibition by a reactive center lysine mutant of the Kunitz-type protease inhibitor domain of the amyloid beta-protein precursor.
Van Nostrand WE; Schmaier AH; Siegel RS; Wagner SL; Raschke WC
J Biol Chem; 1995 Sep; 270(39):22827-30. PubMed ID: 7559414
[TBL] [Abstract][Full Text] [Related]
3. A spider-derived Kunitz-type serine protease inhibitor that acts as a plasmin inhibitor and an elastase inhibitor.
Wan H; Lee KS; Kim BY; Zou FM; Yoon HJ; Je YH; Li J; Jin BR
PLoS One; 2013; 8(1):e53343. PubMed ID: 23308198
[TBL] [Abstract][Full Text] [Related]
4. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
[TBL] [Abstract][Full Text] [Related]
5. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.
Enjyoji K; Miyata T; Kamikubo Y; Kato H
Biochemistry; 1995 May; 34(17):5725-35. PubMed ID: 7727433
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
7. The effect of leukocyte elastase on tissue factor pathway inhibitor.
Higuchi DA; Wun TC; Likert KM; Broze GJ
Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
[TBL] [Abstract][Full Text] [Related]
8. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
Lockett JM; Mast AE
Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
[TBL] [Abstract][Full Text] [Related]
9. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
[TBL] [Abstract][Full Text] [Related]
11. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
Petersen LC; Bjørn SE; Nordfang O
Thromb Haemost; 1992 May; 67(5):537-41. PubMed ID: 1519213
[TBL] [Abstract][Full Text] [Related]
12. Characterization of placental bikunin, a novel human serine protease inhibitor.
Delaria KA; Muller DK; Marlor CW; Brown JE; Das RC; Roczniak SO; Tamburini PP
J Biol Chem; 1997 May; 272(18):12209-14. PubMed ID: 9115295
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
14. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.
Johnson K; Zaror I; Bauer D; Choi Y; Creasey A; Innis M
Thromb Haemost; 1998 Oct; 80(4):585-7. PubMed ID: 9798974
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory properties of human recombinant Arg24-->Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2).
Kamei S; Petersen LC; Sprecher CA; Foster DC; Kisiel W
Thromb Res; 1999 May; 94(3):147-52. PubMed ID: 10326761
[TBL] [Abstract][Full Text] [Related]
16. High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid beta-protein precursor.
Wagner SL; Siegel RS; Vedvick TS; Raschke WC; Van Nostrand WE
Biochem Biophys Res Commun; 1992 Jul; 186(2):1138-45. PubMed ID: 1497647
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification and characterization of a Kunitz-type protease inhibitor domain from human amyloid precursor protein homolog.
Petersen LC; Bjørn SE; Norris F; Norris K; Sprecher C; Foster DC
FEBS Lett; 1994 Jan; 338(1):53-7. PubMed ID: 8307156
[TBL] [Abstract][Full Text] [Related]
18. Two Kazal-type protease inhibitors from Macrobrachium nipponense and Eriocheir sinensis: comparative analysis of structure and activities.
Qian YQ; Li Y; Yang F; Yu YQ; Yang JS; Yang WJ
Fish Shellfish Immunol; 2012 Mar; 32(3):446-58. PubMed ID: 22200638
[TBL] [Abstract][Full Text] [Related]
19. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
Hamamoto T; Kisiel W
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
[TBL] [Abstract][Full Text] [Related]
20. A spider (Araneus ventricosus) chymotrypsin inhibitor that acts as an elastase inhibitor and a microbial serine protease inhibitor.
Wan H; Lee KS; Kim BY; Yuan M; Zhan S; You H; Li J; Jin BR
Comp Biochem Physiol B Biochem Mol Biol; 2013 May; 165(1):36-41. PubMed ID: 23499942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
